{
    "clinical_study": {
        "@rank": "154776", 
        "arm_group": [
            {
                "arm_group_label": "Perineural", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in this group will receive a perineural injection of mepivacaine for subgluteal sciatic nerve block, in addition to a femoral nerve block and patient-controlled postoperative analgesia."
            }, 
            {
                "arm_group_label": "Intraneural", 
                "arm_group_type": "Experimental", 
                "description": "Patients in this group will receive an intraneural injection of mepivacaine for subgluteal sciatic nerve block, in addition to a femoral nerve block and patient-controlled postoperative analgesia."
            }
        ], 
        "brief_summary": {
            "textblock": "This study was designed to assess whether the injection of local anesthetic into the nerve\n      (intraneural), as opposed to around it (perineural), leads to longer anesthesia and\n      analgesia of the leg.\n\n      Some reports of accidental intraneural injection mention an extremely long duration. When\n      different drugs and doses were evaluated in a clinical trial of intraneural injection, a\n      longer-than-expected duration was reported.\n\n      The investigators will compare the two types of injection using the same drug, so as to\n      determine if there is an actual difference in duration."
        }, 
        "brief_title": "Duration of Sciatic Nerve Block After Injection of Local Anesthetic In or Around the Nerve", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Orthopedic Surgical Procedures", 
            "Postoperative Pain"
        ], 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "detailed_description": {
            "textblock": "This randomized, controlled trial will investigate prospectively for differences in sensory\n      and motor block duration after intra- or perineural injection of 1.5% (wt/vol) mepivacaine,\n      a short-acting local anesthetic."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Undergoing non-emergent orthopedic procedure of knee, leg, foot with thigh tourniquet\n\n          -  ASA Physical Status Class I-III\n\n          -  Consenting to surgery under peripheral nerve block anesthesia (sciatic +\n             femoral/saphenous block)\n\n        Exclusion Criteria:\n\n          -  Unable to understand or communicate for the purpose of the study\n\n          -  Exhibiting signs of neuropathy in the ipsilateral extremity\n\n          -  Inability to satisfactorily image the sciatic nerve in the opinion of the attending\n             anesthesiologist"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01981291", 
            "org_study_id": "ANEST-ORT-03"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intraneural", 
                "description": "The injection will start as the needle penetrates the outermost discernible layer of the nerve (epineurium) under ultrasound guidance. The injection will be adjudicated as \"intraneural\" if nerve cross section expansion and a reduction in echogenicity are observed.\nShort-axis real-time ultrasound imaging will be used, with an in-plane needle approach.", 
                "intervention_name": "Intraneural Injection for Subgluteal Sciatic Nerve Block", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "Injection beneath the common investing external layer", 
                    "Subepineural Injection", 
                    "Gluteal sciatic nerve block", 
                    "Subparaneural injection"
                ]
            }, 
            {
                "arm_group_label": "Perineural", 
                "description": "The injection will start as the needle indents the outermost discernible layer of the nerve (epineurium) under ultrasound guidance. The injection will be adjudicated as \"intraneural\" if the drug infiltrates the space between the epimysium of the surrounding muscles and the outer epineurium of the sciatic nerve.\nShort-axis real-time ultrasound imaging will be used, with an in-plane needle approach.", 
                "intervention_name": "Perineural Injection for Subgluteal Sciatic Nerve Block", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "Injection outside the common investing external layer", 
                    "Epineural injection", 
                    "Extraneural injection"
                ]
            }, 
            {
                "arm_group_label": [
                    "Perineural", 
                    "Intraneural"
                ], 
                "description": "Patients will receive an ultrasound-guided femoral nerve block using a short- or long-acting local anesthetic, as deemed indicated.", 
                "intervention_name": "Femoral Nerve Block", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "Perineural", 
                    "Intraneural"
                ], 
                "description": "Patients will receive a patient-controlled intravenous or perineural catheter-based analgesia, depending on their preference and the anesthesiologist's indication.", 
                "intervention_name": "Patient-controlled postoperative analgesia", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "PCA", 
                    "PCIVA", 
                    "PCCPNB", 
                    "Patient-controlled continuous peripheral nerve block"
                ]
            }, 
            {
                "arm_group_label": [
                    "Perineural", 
                    "Intraneural"
                ], 
                "description": "Thirty milliliters of 1.5% (wt/vol) mepivacaine will be used for the sciatic nerve block.", 
                "intervention_name": "Mepivacaine", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Local Anesthetic", 
                    "Carbocaine"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics, Local", 
                "Mepivacaine", 
                "Anesthetics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lower Extremity", 
            "Sciatic Nerve", 
            "Anesthesia, Regional", 
            "Anesthetics, Local", 
            "Mepivacaine", 
            "Ultrasonography"
        ], 
        "lastchanged_date": "November 18, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Parma", 
                    "country": "Italy", 
                    "state": "PR", 
                    "zip": "43126"
                }, 
                "name": "Anesthesia, Critical Care and Pain Medicine \u2014 University of Parma"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Duration of Subgluteal Sciatic Nerve Block After Intra- or Perineural Injection of Mepivacaine: a Randomized, Controlled Trial", 
        "other_outcome": {
            "description": "The minimum electrical nerve stimulation threshold will be recorded as a function of needle tip position.", 
            "measure": "Extra- vs. Intraneural Minimum Electrical Stimulation Thresholds", 
            "safety_issue": "No", 
            "time_frame": "(during the procedure)"
        }, 
        "overall_official": {
            "affiliation": "University of Parma", 
            "last_name": "Marco Baciarello, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The time at which sensory and motor function of the sciatic nerve have recovered at least to the following criteria:\nSensory: patients feel discomfort when pricked with a thin needle (25G)\nMotor: patients may move both toes and ankle, albeit with reduced strength\nThis outcome measure will be examined by an investigator every 30-60 min and reported by patients as \"time to return of sensation and movement\". The investigator-reported value will be preferred if both are available.", 
            "measure": "Differences in Time to Resolution of Sciatic Nerve Block", 
            "safety_issue": "No", 
            "time_frame": "<12 h"
        }, 
        "reference": [
            {
                "PMID": "20630694", 
                "citation": "Benhamou D, Blonski E, L\u00e9vy P, Plessis E, Chalhoub V. Ultra-long duration of a peripheral nerve block: a possible consequence of intraneural (subepineural) local anaesthetic injection. Ann Fr Anesth Reanim. 2010 Jul-Aug;29(7-8):589-91. doi: 10.1016/j.annfar.2010.05.032. Epub 2010 Jul 13."
            }, 
            {
                "PMID": "24108248", 
                "citation": "Nader A, Kendall MC, De Oliveira GS Jr, Puri L, Tureanu L, Brodskaia A, Asher Y, Parimi V, McCarthy RJ. A dose-ranging study of 0.5% bupivacaine or ropivacaine on the success and duration of the ultrasound-guided, nerve-stimulator-assisted sciatic nerve block: a double-blind, randomized clinical trial. Reg Anesth Pain Med. 2013 Nov-Dec;38(6):492-502. doi: 10.1097/AAP.0b013e3182a4bddf."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01981291"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Parma", 
            "investigator_full_name": "Marco Baciarello", 
            "investigator_title": "Assistant Professor, Anesthesia, Critical Care and Pain Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Time to onset of sciatic nerve anesthesia, defined as meeting at least the following criteria:\nSensory: does not feel pain or discomfort when pricked with a 25G needle.\nMotor: able to slightly curl toes; unable to flex the ankle.", 
                "measure": "Block Onset Time", 
                "safety_issue": "No", 
                "time_frame": "\u226430 min"
            }, 
            {
                "description": "The percentage of patients who attain the criteria for block success within 30 minutes of the injeciton.\nInvestigators will also report the percentage of patients who successfully complete surgery without significant additional analgesia (see below); this will be defined as \"clinical success rate.\"", 
                "measure": "Success Rate of Anesthetic Nerve Blocks", 
                "safety_issue": "No", 
                "time_frame": "\u226430 min"
            }, 
            {
                "description": "Patients will be interviewed at ~4 h (block resolution visit), 7 days and (if necessary) at 30 days to assess for residual neurologic disturbances in the sciatic nerve territory.\nThe incidence/prevalence of these phenomena will be noted.", 
                "measure": "Incidence and Prevalence of Neurologic Disturbances", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }
        ], 
        "source": "University of Parma", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Parma", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}